Nan Fung Group Holdings
Latest statistics and disclosures from Nan Fung Group Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ILMN, HRMY, OCS, VRNA, ZLAB, and represent 41.37% of Nan Fung Group Holdings's stock portfolio.
- Added to shares of these 10 stocks: VRNA (+$6.2M), RXRX, RBRK, TRML, KYMR, MIRM, SLNO, BCYC, RVMD, MDGL.
- Started 4 new stock positions in RXRX, Dbv Technologies Sa, VRNA, RBRK.
- Reduced shares in these 9 stocks: Longboard Pharmaceuticals In (-$5.4M), EXAI, , Beigene, INCY, SWTX, RARE, DBVT, AVTE.
- Sold out of its positions in AVTE, BMRN, DBVT, EXAI, Longboard Pharmaceuticals In, SWTX, RARE.
- Nan Fung Group Holdings was a net buyer of stock by $5.3M.
- Nan Fung Group Holdings has $117M in assets under management (AUM), dropping by 0.73%.
- Central Index Key (CIK): 0001782539
Tip: Access up to 7 years of quarterly data
Positions held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 35 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Illumina (ILMN) | 13.6 | $16M | 119k | 133.63 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 10.8 | $13M | 369k | 34.41 |
|
|
| Oculis Holding Ordinary Shares (OCS) | 6.3 | $7.4M | 436k | 17.00 |
|
|
| Verona Pharma Sponsored Ads (VRNA) | 5.3 | $6.2M | NEW | 133k | 46.44 |
|
| Zai Lab Adr (ZLAB) | 5.3 | $6.2M | 235k | 26.19 |
|
|
| Mirum Pharmaceuticals (MIRM) | 4.4 | $5.2M | +18% | 125k | 41.35 |
|
| Merus N V (MRUS) | 4.3 | $5.0M | 120k | 42.05 |
|
|
| Geron Corporation (GERN) | 4.2 | $4.9M | 1.4M | 3.54 |
|
|
| Incyte Corporation (INCY) | 4.0 | $4.6M | -9% | 67k | 69.07 |
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 3.8 | $4.5M | NEW | 665k | 6.76 |
|
| Xenon Pharmaceuticals (XENE) | 3.6 | $4.2M | 107k | 39.20 |
|
|
| Replimune Group (REPL) | 3.3 | $3.9M | +11% | 322k | 12.11 |
|
| Tourmaline Bio (TRML) | 3.2 | $3.8M | +27% | 187k | 20.28 |
|
| Beigene Sponsored Adr | 3.2 | $3.7M | -13% | 20k | 184.71 |
|
| Soleno Therapeutics (SLNO) | 3.1 | $3.6M | +24% | 80k | 44.95 |
|
| Madrigal Pharmaceuticals (MDGL) | 2.9 | $3.4M | +13% | 11k | 308.57 |
|
| D Fluidigm Corp Del (LAB) | 2.8 | $3.3M | 1.9M | 1.75 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 2.4 | $2.7M | 49k | 55.98 |
|
|
| Exelixis (EXEL) | 1.8 | $2.1M | 64k | 33.30 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 1.6 | $1.9M | 103k | 18.35 |
|
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.6 | $1.9M | 14k | 137.67 |
|
|
| Rubrik Cl A (RBRK) | 1.4 | $1.6M | NEW | 24k | 65.36 |
|
| Kalvista Pharmaceuticals (KALV) | 1.1 | $1.3M | 155k | 8.47 |
|
|
| Kymera Therapeutics (KYMR) | 1.1 | $1.2M | +183% | 31k | 40.23 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.8 | $965k | +118% | 69k | 14.00 |
|
| Entrada Therapeutics (TRDA) | 0.7 | $849k | 49k | 17.29 |
|
|
| Revolution Medicines (RVMD) | 0.7 | $842k | +163% | 19k | 43.74 |
|
| Eliem Therapeutics (CLYM) | 0.7 | $835k | 464k | 1.80 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.6 | $676k | 494k | 1.37 |
|
|
| Bolt Biotherapeutics (BOLT) | 0.5 | $624k | 1.2M | 0.54 |
|
|
| Bolt Projs Hldgs (BSLK) | 0.3 | $391k | 812k | 0.48 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $265k | 430.00 | 615.00 |
|
|
| Dbv Technologies S A Sponsored Ads | 0.1 | $115k | NEW | 37k | 3.09 |
|
| Alx Oncology Hldgs (ALXO) | 0.1 | $70k | 42k | 1.67 |
|
|
| Affimed N V Ordinary Shs New (AFMD) | 0.0 | $44k | 37k | 1.19 |
|
Past Filings by Nan Fung Group Holdings
SEC 13F filings are viewable for Nan Fung Group Holdings going back to 2021
- Nan Fung Group Holdings 2024 Q4 filed Feb. 13, 2025
- Nan Fung Group Holdings 2024 Q3 filed Nov. 13, 2024
- Nan Fung Group Holdings 2024 Q2 filed Aug. 13, 2024
- Nan Fung Group Holdings 2024 Q1 filed May 14, 2024
- Nan Fung Group Holdings 2023 Q4 filed Feb. 13, 2024
- Nan Fung Group Holdings 2023 Q3 filed Nov. 13, 2023
- Nan Fung Group Holdings 2023 Q2 filed Aug. 11, 2023
- Nan Fung Group Holdings 2023 Q1 filed May 12, 2023
- Nan Fung Group Holdings 2022 Q4 filed Feb. 13, 2023
- Nan Fung Group Holdings 2022 Q3 filed Nov. 10, 2022
- Nan Fung Group Holdings 2022 Q2 filed Aug. 12, 2022
- Nan Fung Group Holdings 2022 Q1 filed May 13, 2022
- Nan Fung Group Holdings 2021 Q4 filed Feb. 14, 2022
- Nan Fung Group Holdings 2021 Q3 filed Nov. 15, 2021
- Nan Fung Group Holdings 2021 Q2 filed Sept. 22, 2021